background image

Executive Management

[+] Chief Executive Officer
Woosok Lee

Woosok Lee, the President and CEO of TissueGene, brings a broad and multidisciplinary international experience to the company. In addition to his role at TissueGene, Mr. Lee currently serves as the President and CEO of Kolon Pharmaceuticals, Inc., the President and CEO of Kolon ePlatform, Inc., and the President and CEO of Kolon Life Science, Inc. Mr. Lee received his MBA from the UCLA University in Los Angeles, California, and his bachelor’s degree in Economics from the Seoul National University in Korea.

[+] Chief Executive Officer
Bumsup Lee, Ph.D

Bumsup Lee, DVM & PhD, President and CEO of TissueGene, joined TissueGene, Inc. in March, 2014 as Chief Operating Officer. He was the Executive Vice President and CTO of Kolon Life Science, Inc (KLS), a position he held from May 2011 to May 2017, where he was responsible for a full range of R&D, clinical, BD, and manufacturing. Prior to joining KLS, he worked for biotechs and pharmaceutical companies of Dong-A pharm, Mitokor, Syrrx, and Takeda San Diego since 1988 where he advanced multiple drug candidates to clinical stages and won commercialization in the areas of diabetes, arthritis, and cancers. He obtained his DVM and MS in pathology from Seoul National University and his PhD from Iowa State University. He was a postdoctoral fellow at the State University of New York.

[+] Chief Financial Officer
Soon-Wook Kweon

Soon-Wook Kweon joined TissueGene, Inc. in May, 2017 as the Chief Financial Officer. Before he joined TissueGene, he served as the Vice President of Management & Finance Division in Kolon Corporation. He received his Bachelor of Arts in Economics at Korea University in Korea.

[+] Chief Medical Officer
Gurdyal Kalsi, M.D.

Gurdyal Kalsi, M.D. is TissueGene's Chief Medical Officer and Senior Vice President for Clinical Development & Medical Affairs. Dr. Kalsi will oversee and direct clinical development, regulatory and medical affairs functions. Dr. Kalsi most recently served as Corporate Vice President for Clinical Development & Medical Affairs at Emergent BioSolutions Inc. He received his medical degrees in surgery and medicine from Glancy Medical School followed by post graduate training in public health medicine at St George's Hospital in London, and Pharmaceutical Medicine specialist training at Cardiff University, UK.

[+] Chief Technology Officer
Moon J. Noh, Ph.D

Dr. Moon J. Noh joined TissueGene in 2001 as Vice President of Research and Development. Before joining TissueGene, Dr. Noh was the Director of the Biotechnology Lab at Kolon Central Research Park. Dr. Noh holds a PhD and MS from the Korea Advanced Institute of Science and Technology in Molecular Biology.

[+] General Counsel
Sean Woo, JD

Sean Woo joined TissueGene in 2010 as its General Counsel. Mr. Woo is a graduate of Harvard University and Widener University School of Law. He was an associate at the law firm of Duane, Morris and Hecksher in Wilmington, Delaware, before a long career in the federal government. Mr. Woo is currently a member of the Pennsylvania bar.